With proper guidance and monitoring, weight loss progress can continue safely and steadily
arthralgia incidence in trials is generally similar to placebo Rapid weight loss from GLP-1 treatment may alter biomechanical loading on joints, causing temporary adjustment-related discomfort Patients prescribed GLP-1 medications often have type 2 diabetes or obesity, conditions independently associated with increased osteoarthritis rates Seek medical advice for severe, worsening, or persistent joint pain, or if accompanied by swelling, redness, warmth, or systemic symptoms Report suspected medication side effects through the MHRA Yellow Card scheme to support ongoing safety monitoring Table of Contents Understanding GLP-1 Medications and Their Common Side Effects GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), most commonly cause gastrointestinal side effects such as nausea, vomiting, and diarrhoea
March 25, 2026 Wegovy and NAION Risk A new safety signal is emerging with the GLP1 drugs, and it is not a small one
ajkd.org To view or add a comment, sign in As we begin 2026, I am pleased to share that Rezultz is introducing new services to enhance patient care, starting with PGX Testing
But they won't be able to regenerate all the Glucose 6 Phosphate back, as there is the absence of carbon
